Jim Simons Cullinan Oncology, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 334,525 shares of CGEM stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

334,525

Previous 363,008 7.85%

Holding current value

$2.16 Million

Previous $2.75 Million 8.34%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$7.13 - $9.08 $203,083 - $258,625	-28,483 Reduced 7.85%	334,525 $2.52 Million
Q1 2025 May 14, 2025	BUY	$7.57 - $12.68 $1.31 Million - $2.19 Million	172,500 Added 90.55%	363,008 $2.75 Million
Q4 2024 Feb 13, 2025	SELL	$10.77 - $17.6 $983,214 - $1.61 Million	-91,292 Reduced 32.4%	190,508 $2.32 Million
Q3 2024 Nov 13, 2024	SELL	$16.03 - $20.86 $2.24 Million - $2.92 Million	-139,908 Reduced 33.18%	281,800 $4.72 Million
Q2 2024 Aug 09, 2024	BUY	$15.63 - $29.35 $1.57 Million - $2.95 Million	100,608 Added 31.33%	421,708 $7.35 Million
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $579,812 - $1.08 Million	57,012 Added 21.59%	321,100 $5.47 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $10.23 $326,551 - $423,399	41,388 Added 18.58%	264,088 $2.69 Million
Q3 2023 Nov 14, 2023	SELL	$9.05 - $11.72 $207,245 - $268,388	-22,900 Reduced 9.32%	222,700 $2.02 Million
Q2 2023 Aug 11, 2023	BUY	$8.8 - $13.4 $56,320 - $85,760	6,400 Added 2.68%	245,600 $2.64 Million
Q1 2023 May 12, 2023	SELL	$10.2 - $11.91 $698,700 - $815,835	-68,500 Reduced 22.26%	239,200 $2.45 Million
Q4 2022 Feb 13, 2023	BUY	$9.72 - $13.62 $53,508 - $74,978	5,505 Added 1.82%	307,700 $3.25 Million
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $101,592 - $132,534	8,595 Added 2.93%	302,195 $3.87 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $13.55 $2.15 Million - $3.98 Million	293,600 New	293,600 $3.76 Million
Q1 2022 May 13, 2022	SELL	$10.47 - $16.75 $278,502 - $445,550	-26,600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.36 - $25.0 $408,576 - $665,000	26,600 New	26,600 $410,000
Q3 2021 Nov 12, 2021	SELL	$22.56 - $29.68 $586,153 - $771,145	-25,982 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$24.96 - $41.25 $648,510 - $1.07 Million	25,982 New	25,982 $669,000

Others Institutions Holding CGEM

# of Institutions

153

Shares Held

66.7M

Call Options Held

10.6K

Put Options Held

917K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $294M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account